Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
Clinical trial NCT01889862 · COMPLETED
Trial details
- NCT number
- NCT01889862
- Sponsor
- BioMarin Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-29
- Primary completion
- 2016-01-13
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.